{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:33:01Z","timestamp":1779301981830,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ijid.2021.06.022","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T18:46:27Z","timestamp":1623782787000},"page":"557-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2959-571X","authenticated-orcid":false,"given":"Ignacio","family":"Monedero-Recuero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medea","family":"Gegia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3283-9965","authenticated-orcid":false,"given":"Douglas Fraser","family":"Wares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarabjit S.","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6658-0325","authenticated-orcid":false,"given":"Fuad","family":"Mirzayev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.06.022_bib0005","article-title":"The potential impact of the COVID-19 pandemic on the tuberculosis epidemic: a modelling analysis","volume":"28","author":"Cilloni","year":"2020","journal-title":"EClinMed"},{"key":"10.1016\/j.ijid.2021.06.022_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5588\/ijtld.18.0866","article-title":"Health care gaps in the global burden of drug-resistant tuberculosis","volume":"23","author":"Cox","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2021.06.022_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5588\/ijtld.20.0598","article-title":"Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa","volume":"25","author":"De Vos","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2021.06.022_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/ijmr.IJMR_660_18","article-title":"Ending tuberculosis in India: a political challenge and an opportunity","volume":"147","author":"Dias","year":"2018","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijid.2021.06.022_bib0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(16)30132-3","article-title":"Global burden of drug-resistant tuberculosis in children: a mathematical modelling study","volume":"16","author":"Dodd","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.022_bib0030","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/S2352-3018(20)30359-3","article-title":"The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis","volume":"8","author":"Dorward","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ijid.2021.06.022_bib0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1473-3099(12)70033-6","article-title":"Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Ettehad","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2021.06.022_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00915-19","article-title":"Acquisition of cross-resistance to bedaquiline and clofazimine following treatment for tuberculosis in Pakistan","volume":"63","author":"Ghodousi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.06.022_bib0045","article-title":"Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020","volume":"2020","author":"Glaziou","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijid.2021.06.022_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S2213-2600(19)30418-7","article-title":"WHO global progress report on tuberculosis elimination","volume":"8","author":"Harding","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijid.2021.06.022_bib0055","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1016\/S2214-109X(20)30288-6","article-title":"Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study","volume":"8","author":"Hogan","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2021.06.022_bib0060","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1126\/science.abb5793","article-title":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period","volume":"368","author":"Kissler","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.06.022_bib0065","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","article-title":"Drivers of tuberculosis epidemics: the role of risk factors and social determinants","volume":"68","author":"Lonnroth","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ijid.2021.06.022_bib0070","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41591-020-0917-1","article-title":"The fight to end tuberculosis must not be forgotten in the COVID-19 outbreak","volume":"26","author":"Manyazewal","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2021.06.022_bib0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/17476348.2017.1335599","article-title":"The paradigm shift to end tuberculosis. Are we ready to assume the changes?","volume":"11","author":"Monedero","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ijid.2021.06.022_bib0080","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/S2666-5247(20)30031-8","article-title":"Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in Southern Africa: a phenotypic and phylogenetic analysis","volume":"1","author":"Nimmo","year":"2020","journal-title":"Lancet Microbe"},{"issue":"5","key":"10.1016\/j.ijid.2021.06.022_bib0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/microbiolspec.TBTB2-0019-2016","article-title":"Tuberculosis diagnostics: state of the art and future directions","volume":"4","author":"Pai","year":"2016","journal-title":"Microbiology Spectrum"},{"key":"10.1016\/j.ijid.2021.06.022_bib0090","article-title":"Improving quality is necessary to building a TB-free world: Lancet Commission on Tuberculosis","volume":"19","author":"Reid","year":"2020","journal-title":"J Clin TB Other Mycobact Dis"},{"key":"10.1016\/j.ijid.2021.06.022_bib0095","series-title":"MDR-TB diagnosis and treatment targets after UNHLM","author":"Stop TB Partnership","year":"2019"},{"key":"10.1016\/j.ijid.2021.06.022_bib0100","series-title":"The potential impact of the COVID-19 response on tuberculosis in high-burden countries: a modelling analysis","author":"Stop TB Partnership","year":"2020"},{"key":"10.1016\/j.ijid.2021.06.022_bib0105","author":"Stop TB Partnership","year":"2020"},{"key":"10.1016\/j.ijid.2021.06.022_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002754","article-title":"Constructing care cascades for active tuberculosis: a strategy for program monitoring and identifying gaps in quality of care","volume":"16","author":"Subbaraman","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2021.06.022_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229284","article-title":"Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: a ten year national retrospective cohort study","volume":"15","author":"Tola","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2021.06.022_bib0120","series-title":"Political declaration of the High-Level Meeting of the General Assembly on the fight against tuberculosis. Resolution 73\/3 adopted by the General Assembly on 10 October 2018. United Nations A\/RES\/73\/3","author":"United Nations General Assembly","year":"2018"},{"key":"10.1016\/j.ijid.2021.06.022_bib0125","series-title":"Report of the Secretary-General. Progress towards achieving global tuberculosis targets and implementation of the UN political declaration on tuberculosis. A\/75\/236","author":"United Nations General Assembly","year":"2020"},{"key":"10.1016\/j.ijid.2021.06.022_bib0130","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/AAC.42.7.1853","article-title":"Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis","volume":"42","author":"Williams","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2021.06.022_bib0135","series-title":"Country classification","author":"World Bank Country and Lending Groups","year":"2020"},{"key":"10.1016\/j.ijid.2021.06.022_bib0140","series-title":"Global tuberculosis report 2019. WHO\/CDS\/TB\/2019.152019","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.ijid.2021.06.022_bib0145","series-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.ijid.2021.06.022_bib0150","series-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.ijid.2021.06.022_bib0155","series-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment \u2013 drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2020"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221005117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:02:33Z","timestamp":1761120153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221005117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"alternative-id":["S1201971221005117"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.06.022","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Situational analysis of 10 countries with a high burden of drug-resistant tuberculosis 2 years post-UNHLM declaration: progress and setbacks in a changing landscape","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}